Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/48726
DC FieldValueLanguage
dc.contributor.authorNavarro, D.
dc.contributor.authorCabrera, J. J.
dc.contributor.authorFalcón, O.
dc.contributor.authorJimenez, P.
dc.contributor.authorRuiz, A.
dc.contributor.authorChirino, R.
dc.contributor.authorLópez, A.
dc.contributor.authorRivero, J. F.
dc.contributor.authorDíaz-Chico, J. C.
dc.contributor.authorDíaz-Chico, B. N.
dc.date.accessioned2018-11-24T00:24:28Z-
dc.date.available2018-11-24T00:24:28Z-
dc.date.issued1989
dc.identifier.issn0022-4731
dc.identifier.urihttp://hdl.handle.net/10553/48726-
dc.description.abstractUterine leiomyoma occurs in one of every four or five women during their reproductive life. Its origin is unknown but it is accepted that estrogens play a significant role in its development. In order to learn more about the estrogen dependency of leiomymoma, the biochemical and immunological properties of two markers of estrogen response in target cells (the progesterone receptor (PR) and the stress-responsive protein of 27 kDa (SRP27)) were studied in leiomyoma. The ER (estrogen receptor) and PR content were determined by conventional DCC exchange assays. Specific anti-ER, anti-PR and anti-SRP27 monoclonal antibodies were used in immunoblots and immunohistochemical (IHC) studies. The binding properties of PR from cytosol of leiomyoma showed a Kd of 0.8-1.3 nM, which is in the range described for other human tissues. 80% of all studied leiomyoma contained PR, in a range of 805-2000 fmol/mg protein. The Kd for leiomyoma ER was 0.1-0.9 nM, and 84% of the samples were positive for ER. The PR of leiomyoma has the two A and B forms of 120 and 94 kDa, as shown in the immunoblot using the AB52 anti-PR monoclonal antibody. The IHC study revealed that the PR is concentrated in the cell nuclei, in the form of perinuclear bodies, with a homogeneous staining pattern from cell to cell. The leiomyoma fibres contain SRP27 in a higher concentration than the healthy myometrium. The leiomyoma SRP27 shows a typical doublet of 24 kDa and 27 kDa in immunoblot, the same as in MCF-7 cells. The IHC study revealed a high degree of organization of SRP27 in leiomyoma cells, suggesting that this protein may be part of the cytoskeleton. The results obtained show that human leiomyomas contain ER, PR and RSP27 with similar immunological and biochemical properties to those of other human tissues, including the MCF-7 breast cancer cell line. © 1989.
dc.publisher0022-4731
dc.relation.ispartofJournal of Steroid Biochemistry
dc.sourceJournal of Steroid Biochemistry[ISSN 0022-4731],v. 34, p. 491-498
dc.titleMonoclonal antibody characterization of progesterone receptors, estrogen receptors and the stress-responsive protein of 27 kDa (SRP27) in human uterine leiomyoma
dc.typeinfo:eu-repo/semantics/Articlees
dc.typeArticlees
dc.identifier.doi10.1016/0022-4731(89)90133-7
dc.identifier.scopus0024843615
dc.contributor.authorscopusid7004873659
dc.contributor.authorscopusid6602257053
dc.contributor.authorscopusid6603752888
dc.contributor.authorscopusid57197533993
dc.contributor.authorscopusid57201387360
dc.contributor.authorscopusid6701324062
dc.contributor.authorscopusid57206586568
dc.contributor.authorscopusid57206586568
dc.contributor.authorscopusid7006478821
dc.contributor.authorscopusid6701492347
dc.contributor.authorscopusid7003603506
dc.description.lastpage498
dc.description.firstpage491
dc.relation.volume34
dc.type2Artículoes
dc.date.coverdateEnero 1989
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptDepartamento de Morfología-
crisitem.author.deptFarmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética E Inmunología.-
crisitem.author.deptDiabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética E Inmunología.-
crisitem.author.deptBioquímica Farmacológica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética E Inmunología.-
crisitem.author.deptFarmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0002-4184-6403-
crisitem.author.orcid0000-0002-0944-990X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameCabrera Galván, Juan José-
crisitem.author.fullNameChirino Godoy, Ricardo-
crisitem.author.fullNameDíaz Chico, Juan Carlos-
crisitem.author.fullNameDíaz Chico, Bonifacio-
crisitem.author.departamentoMorfología-
crisitem.author.departamentoBioquímica y Biología Molecular, Fisiología, Genética E Inmunología.-
crisitem.author.departamentoBioquímica y Biología Molecular, Fisiología, Genética E Inmunología.-
crisitem.author.departamentoBioquímica y Biología Molecular, Fisiología, Genética E Inmunología.-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

15
checked on May 31, 2020

Page view(s)

7
checked on May 30, 2020

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.